Institute of Cancer Research
Priority Announcements fund highly rated research applications that are determined to be relevant to specific CIHR research priority areas and do not receive funding through CIHR's regular competitions.
| Important Dates | |
| Opportunity Launched | June 2006 |
| Content Last Updated | (No updates since launch) |
| August 15, 2006 | Registration Deadline - Registration packages must be courier stamped by this date. |
| September 15, 2006 | Full applications must be courier stamped by this date. |
| February 1, 2007 | Anticipated notification of decision. |
| April 1, 2007 | Anticipated start date. |
| Additional Information | Applications are submitted through the September 2006 - Operating Grants competition |
| Funds Available | |
| CIHR's contribution to the amount available for this initiative is subject to availability of funds voted annually to CIHR by parliamentary appropriations, and the conditions that may be attached to them. The maximum amount awarded will be $ 120,000 per grant for up to one year. The funding provided through this priority announcement is non-renewable. Funding for a further period may be possible through an application to a regular Operating Grants competition sufficiently far in advance of the termination date of the grant to ensure continuity. Applications receiving a rating of less than 3.5 will not be considered for funding. | |
| Summary | |
| Part of mandate of the CIHR Institute of Cancer Research is to promote research that addresses the reduction of the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatment, psycho-social support systems, and palliation. The purpose of this Priority Announcement is to further strengthen Canadian cancer research by offering short-term funding to those researchers who submit excellent operating grant applications, but are not funded due to CIHR's financial constraints. It is expected that this targeted investment will prevent cancer research teams from disbanding prematurely and lead to successful applications in future competitions. | |
Objectives
Eligibility
Review Process and Evaluation Criteria
General CIHR Guidelines
Conditions of Funding
How to Apply
Contact Information
The objective of this priority announcement is to offer short-term support to researchers who submit excellent cancer research operating grant applications that are not funded through the regular CIHR competition to which they were submitted. This funding is awarded to allow these excellent researchers to reapply to future competitions without interruption of funding.
Relevant Research Areas
Through this funding opportunity, the CIHR Institute of Cancer Research will strengthen research that relates to its mandate.
Upon completion of peer review, the Institute of Cancer Research will receive the ranking lists and peer review committee recommendations on funding level and grant or award term for all applications 1) that are rated within the CIHR fundable range but are not funded through the regular CIHR competition to which they were submitted; and 2) in which Institute of Cancer Research was selected as primary choice in the "Suggested CIHR Institute(s)" section of the Research Module (see "How to Apply"). These applications will be funded from the top down in order of ranking as far as budgets will allow. Applications that receive a rating below 3.5 will not be funded.
The decision to fund research applications based on their relevance to the mandate occurs apart from the peer review (scientific review) and has no relationship to the results of peer review. Peer review committees will not be informed of applications submitted for funding through this announcement.
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Nominated Principal Applicant generally administers CIHR funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
A CIHR peer review committee will evaluate the full applications. The peer review committee members are selected based on suggestions from many sources including the Institute(s) / portfolio(s) and partner(s), following CIHR's Policy on Confidentiality, Conflict of Interest and Privacy Issues in Peer and Relevance Review (CCIP). For information on CIHR's peer review process in general, see Peer Review.
This Priority Announcement will follow the CIHR General Grants and Awards Policies. Applicants are encouraged to demonstrate the use of gender and sex-based analysis in applications.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Priority Announcement. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR Support. Successful applicants will be informed of any special financial conditions prior to the release of funds or when they receive CIHR's Authorization for Funding (AFF) document.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
All personal information collected by CIHR about applicants is used to review applications, to recruit reviewers, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by CIHR may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in CIHR's premises including, without limitation, cost-sharing agreements related to this priority announcement and all matters pertaining thereto.
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the priority announcement will be collected, used and disclosed in compliance with the PIPEDA.
Applicants are advised to review CIHR's grants and awards policies and guidelines outlined in the CIHR Grants and Awards Guide.
Applications are submitted through the September 2006 - Operating Grants competition. To select the appropriate application forms, follow the links beside "Operating Grants" from the list of Application Packages)
Additional Instructions for this Priority Announcement:
For questions about the objectives and relevant research areas:
Benoît Lussier
Assistant Director
CIHR Institute of Cancer Research
3655 Promenade Sire William Osler
Suite 701
Montreal, QC H3G 1Y6
Telephone: (514) 398-4964
Fax: (514) 398-8845
Email: benoit.lussier@mcgill.ca
For questions related to specific CIHR competitions and programs, including CIHR funding guidelines, how to apply, and the peer review process contact:
Jonathan Faulkner
Program Delivery Coordinator
Canadian Institutes of Health Research
Telephone: (613) 946-6568
Fax: (613) 954-1800
Email: jfaulkner@cihr-irsc.gc.ca
